IEG Vu is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marrone seeks further Nasdaq listing extension

The US biopesticide company, Marrone Bio Innovations (MBI - Davis, California), is to request a hearing by the listing qualifications panel of the Nasdaq stock exchange for a further extension to file its financial reports. The company was granted an extension in February to file any delinquent reports by May 13th and regain compliance with the Nasdaq's listing rules. It had been ordered to submit a plan to regain compliance after failing to submit its financial results for the third quarter of 2014. It was investigating an $870,000 transaction in the fourth quarter of 2013. MBI says that it does not expect to file its financial report for the first quarter of 2015 on time, resulting in further non-compliance with Nasdaq listing rules. The listing qualifications panel has the authority to continue the company's listing on the Nasdaq until November 2nd 2015, MBI points out.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022385

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel